Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Patterson

Showing results (581-590 of 698) with videos related to

Pageof 70
Sort By:
Plos One|March 10, 2021
Informed consent rates for neonatal randomized controlled trials in low- and lower middle-income versus high-income countries: A systematic reviewJacquelyn K Patterson, Stuti Pant, Denise F Jones, et al.
Journal of Clinical Pharmacology|May 1, 1997
Pharmacokinetics of zileuton and its metabolites in patients with renal impairmentW M Awni, S Wong, S Y Chu, et al.
AIDS (London, England)|June 12, 2003
Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cellsAnnelie Tjernlund, Zareefa Fleener, Homira Behbahani, et al.
Biochemistry|April 7, 2007
Interplay of oxygen, vitamin E, and carotenoids in radical reactions following oxidation of Trp and Tyr residues in native HDL3 apolipoproteins. Comparison with LDL. A time-resolved spectroscopic analysisAgnès Boullier, Jean-Claude Mazière, Paulo Filipe, et al.
Environmental Science & Technology|November 8, 2012
Assimilation of oil-derived elements by oysters due to the Deepwater Horizon Oil SpillRuth H Carmichael, Amanda L Jones, Heather K Patterson, et al.
Pharmacoeconomics - Open|September 13, 2018
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in EnglandD Lee, A Amadi, J Sabater, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1Ed Kellar, Susan M Bornstein, Aleny Caban, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2007
Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infectionHomira Behbahani, Lilian Walther-Jallow, Elin Klareskog, et al.
Pharmacoeconomics - Open|May 24, 2018
Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in EnglandD Lee, A Amadi, J Sabater, et al.
The Journal of Experimental Medicine|May 16, 1998
Productive infection of neonatal CD8+ T lymphocytes by HIV-1L P Yang, J L Riley, R G Carroll, et al.
Pageof 70

Showing results (581-590 of 698) with videos related to

Sort By:
Pageof 70
Plos One|March 10, 2021
Informed consent rates for neonatal randomized controlled trials in low- and lower middle-income versus high-income countries: A systematic reviewJacquelyn K Patterson, Stuti Pant, Denise F Jones, et al.
Journal of Clinical Pharmacology|May 1, 1997
Pharmacokinetics of zileuton and its metabolites in patients with renal impairmentW M Awni, S Wong, S Y Chu, et al.
AIDS (London, England)|June 12, 2003
Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cellsAnnelie Tjernlund, Zareefa Fleener, Homira Behbahani, et al.
Biochemistry|April 7, 2007
Interplay of oxygen, vitamin E, and carotenoids in radical reactions following oxidation of Trp and Tyr residues in native HDL3 apolipoproteins. Comparison with LDL. A time-resolved spectroscopic analysisAgnès Boullier, Jean-Claude Mazière, Paulo Filipe, et al.
Environmental Science & Technology|November 8, 2012
Assimilation of oil-derived elements by oysters due to the Deepwater Horizon Oil SpillRuth H Carmichael, Amanda L Jones, Heather K Patterson, et al.
Pharmacoeconomics - Open|September 13, 2018
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in EnglandD Lee, A Amadi, J Sabater, et al.
Therapeutic Innovation & Regulatory Science|September 21, 2018
Optimizing the Use of Electronic Data Sources in Clinical Trials: The Landscape, Part 1Ed Kellar, Susan M Bornstein, Aleny Caban, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 16, 2007
Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human papillomavirus infectionHomira Behbahani, Lilian Walther-Jallow, Elin Klareskog, et al.
Pharmacoeconomics - Open|May 24, 2018
Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in EnglandD Lee, A Amadi, J Sabater, et al.
The Journal of Experimental Medicine|May 16, 1998
Productive infection of neonatal CD8+ T lymphocytes by HIV-1L P Yang, J L Riley, R G Carroll, et al.
Pageof 70